MyHeart: fighting cardiovascular disease by preventive lifestyle and early diagnosis

Josef Lauter1

  • 1Philips Research Laboratories, Weishausstrasse 2, 52066 Aachen, Germany.

Insights

The MyHeart project aims to combat cardiovascular diseases (CVD) through smart electronic systems for prevention and early diagnosis. It empowers users to manage their health, benefiting healthy individuals, at-risk populations, and chronically ill patients.

Area of Science:

  • Biomedical Engineering
  • Health Informatics
  • Cardiovascular Medicine

Background:

  • Cardiovascular diseases (CVD) represent a significant global health challenge.
  • Existing healthcare systems often lack integrated solutions for CVD prevention and management.
  • There is a growing need for user-centric technologies to empower individuals in managing their cardiovascular health.

Purpose of the Study:

  • To develop integrated smart electronic systems and services for the prevention and early diagnosis of cardiovascular diseases.
  • To empower users to take proactive control of their health status.
  • To create business options for lifelong cardiovascular health solutions.

Main Methods:

  • An integrated project approach under the 6th framework programme of the European Commission.
  • Leveraging Philips Research Aachen's leadership in smart electronic systems.
  • Developing a wide variety of applications tailored to the cardiovascular disease space.

Main Results:

  • The project aims to create viable business options for CVD management.
  • Development of smart systems and services to enhance user health control.
  • Solutions designed for diverse user groups including healthy, at-risk, and chronically ill individuals.

Conclusions:

  • The MyHeart project is poised to advance CVD prevention and early diagnosis through innovative technology.
  • Empowering users with smart systems can lead to better self-management of cardiovascular health.
  • Lifelong solutions are essential for addressing the spectrum of cardiovascular health needs.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...